According to the integrated results, we found that increased NALCN expression negatively impacted the prognosis of BLCA, CESC, COAD, HNSC, KIRC, KIRP, and SARC, but positively affected the prognosis of ACC and LGG. This evidence concerns the gene NALCN and adrenal cortex carcinoma.